This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Secondary sideroblastic anaemia due to drugs and toxins
SECONDA_SIDEROBLASTIC_ANAEM_DRUGS_TOXINS
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
24 |
4. Check minimum number of eventsNone |
24 |
5. Include endpointsNone |
24 |
6. Filter based on genotype QC (FinnGen only) |
24 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Secondary sideroblastic anaemia due to drugs and toxins
based on the number of shared cases.
Similar with more cases:
- Secondary sideroblastic anaemia
- Other anaemias
- Aplastic and other anaemias
- Anaemias
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 262 | 166 | 93 |
| Only index persons | 173 | 112 | 61 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.00 | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
| Median age at first event (years) | |||
| Whole population | 70.46 | 70.82 | 70.24 |
| Only index persons | 68.59 | 68.69 | 68.41 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 24 | 17 | 7 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.00 |
| Median age at first event (years) | 67.32 | 66.12 | 70.24 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4281824)
9
0
+∞
10.06
1.6
0.0
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
9
10
13.50
5.33
2.9
3.5
e6/l
0.8
0.0
—
9
10
(3013512) EKG study
17
62
6.91
4.78
3.6
4.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
15
60
4.96
3.32
5.3
2.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
9
25
5.11
2.95
2.9
3.2
e6/l
7.2
2.9
—
9
13
(3003694) ABO and Rh group [Type] in Blood
12
46
4.22
2.89
1.6
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
13
53
4.17
2.88
2.5
2.9
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
14
61
4.11
2.82
2.7
3.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
17
87
4.25
2.79
7.5
4.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
6
11
6.85
2.72
1.5
2.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
13
56
3.88
2.62
2.8
3.4
e6/l
26.9
1221.3
0.52
13
43
(3021589) Normoblasts [#/volume] in Blood
14
73
3.20
1.96
33.6
10.5
e9/l
0.0
0.0
0.49
14
60
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
14
74
3.14
1.90
4.1
3.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
10
44
3.18
1.83
2.5
3.2
%
96.9
93.6
—
10
44
(3018095) Leukocytes [#/volume] in Urine
13
67
3.05
1.83
5.8
4.3
e6/l
40.8
48.4
0.08
13
46
(4035726)
6
19
3.85
1.79
1.3
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
11
52
3.06
1.78
6.5
4.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
9
40
2.98
1.63
1.7
2.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
15
93
2.62
1.53
9.3
5.5
mmol/l
1.2
1.2
0.50
15
75
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
0
39
0.00
1.50
0.0
1.2
—
1.4
—
0
12
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
0
40
0.00
1.50
0.0
1.2
—
16.7
—
0
16
(3032080) INR in Blood by Coagulation assay
13
73
2.70
1.49
1.9
9.6
inr
1.1
1.3
—
6
26
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
9
44
2.66
1.47
1.4
1.6
mg/l
1.8
0.9
—
9
39
(3013650) Neutrophils [#/volume] in Blood by Automated count
16
105
2.56
1.29
24.7
11.2
e9/l
4.3
4.1
0.19
16
96
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
8
40
2.49
1.27
1.1
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
11
63
2.38
1.14
3.1
2.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
6
106
0.42
1.07
1.7
2.9
—
—
—
0
0
(40758558) Short blood count panel - Blood
8
42
2.35
1.02
21.5
9.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
8
47
2.05
0.92
4.8
3.5
—
1.0
—
0
6
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
0
24
0.00
0.84
0.0
1.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
13
88
2.04
0.84
8.4
4.6
mmol/l
1.2
1.2
0.51
13
75
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
0
27
0.00
0.83
0.0
1.9
—
—
—
0
0
(3002256) Pathology report gross observation
5
24
2.36
0.80
1.2
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
5
27
2.07
0.73
1.0
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
20
0.00
0.63
0.0
1.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
6
37
1.82
0.61
3.7
4.8
—
—
—
0
0
(3015736) pH of Urine
5
80
0.53
0.59
7.0
3.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
18
153
1.70
0.43
48.4
17.6
%
15.5
14.0
1.67
18
148
(3000492) Spirometry study
0
15
0.00
0.43
0.0
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.43
0.0
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
0
16
0.00
0.43
0.0
3.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
0
17
0.00
0.42
0.0
1.6
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
19
205
0.65
0.42
59.1
22.2
e9/l
7.1
6.5
0.55
19
200
(3026361) Erythrocytes [#/volume] in Blood
19
205
0.65
0.42
59.1
22.2
e12/l
3.6
4.4
5.21
19
200
(3030467) Casts [#/volume] in Urine by Automated count
7
50
1.56
0.36
1.7
3.2
e6/l
0.2
0.2
—
7
38
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
8
61
1.46
0.33
2.8
3.6
ng/l
3333.4
2752.0
—
8
50
(3013115) Eosinophils [#/volume] in Blood
12
98
1.45
0.29
5.9
5.1
e9/l
0.2
0.2
0.12
12
90
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
10
80
1.43
0.26
2.1
1.9
pmol/l
77.6
107.2
—
5
34
(3003338) MCHC [Mass/volume]
13
150
0.71
0.25
21.3
18.7
g/l
329.2
330.1
0.15
13
150
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
11
0.00
0.22
0.0
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
0
11
0.00
0.22
0.0
2.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.22
0.0
1.7
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
10
0.00
0.22
0.0
1.0
—
9.7
—
0
10
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(4010399)
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
11
93
1.34
0.19
6.4
5.2
e9/l
0.8
0.6
1.62
11
82
(40768804) Tissue Pathology biopsy report
9
79
1.22
0.18
3.6
2.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
15
135
1.30
0.18
4.4
4.9
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
11
94
1.31
0.17
6.4
5.1
e9/l
0.0
0.0
0.14
11
84
(3019198) Lymphocytes [#/volume] in Blood
11
96
1.27
0.13
6.7
5.5
e9/l
1.7
1.8
0.03
11
88
(3022096) Basophils/100 leukocytes in Blood
10
87
1.26
0.12
6.8
4.9
%
0.4
0.7
—
10
80
(3020564) Creatinine [Moles/volume] in Serum or Plasma
19
194
0.90
0.10
46.4
18.0
umol/l
98.7
74.8
0.57
19
194
(42870588) Differential panel, method unspecified - Blood
7
66
1.09
0.09
7.0
4.5
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
10
89
1.21
0.08
6.8
5.2
%
12.6
8.3
—
10
83
(3006504) Eosinophils/100 leukocytes in Blood
10
89
1.21
0.08
6.8
5.0
%
2.1
2.7
—
10
83
(3044889) 12 lead EKG panel
14
130
1.18
0.07
3.8
4.0
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
10
91
1.17
0.05
6.9
5.2
%
58.6
57.4
—
10
84
(3002030) Lymphocytes/100 leukocytes in Blood
10
92
1.15
0.04
7.0
5.3
%
22.5
27.6
—
10
84
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
499.7
—
0
6
(3000764) Benzodiazepines [Presence] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
19
192
0.95
0.00
48.9
16.9
mmol/l
4.0
4.0
0.42
19
184
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
19
189
1.03
0.00
26.2
15.3
mg/l
40.3
19.4
1.44
19
146
(40761511) CBC panel - Blood by Automated count
19
192
0.95
0.00
44.5
13.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
19
192
0.95
0.00
48.8
16.8
mmol/l
137.4
139.8
2.46
19
184
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
0
6
0.00
0.00
0.0
2.8
—
22.8
—
0
6
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.0
—
36.9
—
0
9
(3005033) Fetal Nuchal fold Thickness US
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.0
—
0.0
—
0
9
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.0
—
149.2
—
0
5
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.0
—
0.0
—
0
9
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
1.1
—
0
8
(3004616) Nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
0.2
—
0
8
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
5
49
1.03
0.00
4.2
2.7
mmol/l
6.3
6.8
—
5
34
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
13.2
—
0
5
(3023420) DNA double strand Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
0
9
0.00
0.00
0.0
6.6
—
25.9
—
0
9
(1002224) Polysomnography panel
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
16.8
—
0
5
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
0
9
0.00
0.00
0.0
6.6
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
6
61
0.98
0.00
4.0
2.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint SECONDA_SIDEROBLASTIC_ANAEM_DRUGS_TOXINS and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have SECONDA_SIDEROBLASTIC_ANAEM_DRUGS_TOXINS.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: SECONDA_SIDEROBLASTIC_ANAEM_DRUGS_TOXINS – Secondary sideroblastic anaemia due to drugs and toxins
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data